This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Wearable, long-term continuous heart monitors helped identify 52% more cases of atrialfibrillation compared to usual care, but that did not lead to a reduction in hospitalizations due to stroke, according to a new study.
During its Annual Conference, HRS 2024, the HeartRhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrialfibrillation (AF). Lucas Boersma , electrophysiologist, St.
An international consensus statement on how to treat atrialfibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrialfibrillation ablation, Musat et al. recommend shortening the blanking period from three months to one. Lead author Jonathan M. also emphasize the importance of continuous monitoring.
Ioannis Katsoularis, image courtesy of Klas Sjöberg milla1cf Thu, 12/14/2023 - 09:23 December 14, 2023 — Individuals infected with COVID-19 are also at an increased risk of suffering from heartrhythm disturbances, such as atrialfibrillation.
a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced its participation at the HeartRhythm 2024 conference, taking place in person at the Boston Convention & Exhibition Center and virtually, May 16-19, 2024. EDT, in Rhythm Theater #2.
milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heartrhythms such as atrialfibrillation (AFib).
tim.hodson Mon, 03/03/2025 - 16:26 March 1, 202 One in three people worldwide will develop a potentially life-threatening heartrhythm disorder in their lifetime, yet awareness remains critically low. While some heartrhythm disorders are harmless, others can lead to severe complications.
16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrialfibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time. Piccini, M.D.,
male with pertinent past medical history including Atrialfibrillation, atrial flutter, cardiomyopathy, Pulmonary Embolism, and hypertension presented to the Emergency Department via ambulance for respiratory distress and tachycardia. He was noted to have irregular heartrhythm with rates 120-170s.
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment 5. Scientists Suggest a New Method for Diagnosing Heart Diseases 6. Weight Loss Drug Linked with Reduced Need for Diuretics in Heart Failure Patients 7. Tenax Therapeutics Announces New U.S.
care pathways and to provide millions of Americans with the ability to just use their smartphone to obtain easy and accurate heartrhythm measurements. These measurements can enable the early detection and monitoring of heartrhythm conditions such as atrialfibrillation. and a specificity of 99.9%.1
Atrialfibrillation (AF) is the most common heartrhythm disorder in clinical practice. However, most research in this area has focused on hospital patients.
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation [abstract].
tim.hodson Thu, 03/27/2025 - 12:18 March 27, 2025 Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrialfibrillation (AFib). Helmut Puererfellner at Ordensklinikum hospital in Linz, Austria; Prof. 3 Following approval, initial cases were completed by Prof.
Higher hospital and physician atrialfibrillation (AFib) ablation procedure volumes were associated with increased acute procedural success and lower rates of major adverse events (MAEs), according to a study published in HeartRhythm.
milla1cf Fri, 05/17/2024 - 18:54 May 17, 2024 — Royal Philips , a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the HeartRhythm Annual Meeting in Boston (May 16-19).
intermittent) atrialfibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. intermittent) atrialfibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. director of electrophysiology, Mount Sinai Fuster HeartHospital , New York.
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrialfibrillation (AFib).
Continue reading to learn more about this procedure, its significance in treating atrialfibrillation, and what to expect during treatment. What is AtrialFibrillation? Before diving into electrical cardioversion, we should understand atrialfibrillation (AF). What Is Cardioversion?
In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrialfibrillation ( AF ) using pulsed field ablation (PFA). AtrialFibrillation. Circulation.
The most traditional and the most common method for detecting heartrhythm abnormalities is manual Holter ECG analysis. In addition, it can quickly detect up to 20 heartrhythm abnormalities and identify signatures which take time to be properly recognized by human interpreters.
It can only suggest that there are some heartrhythm abnormalities in the signal, but it does not indicate where they are, how long they last, or what they really mean in terms of the whole signal. Michael Kühne MD, Head of Clinic AtrialFibrillation at University Hospital Basel in Switzerland.
Diagnosis : Atrial flutter with 1:1 conduction, with fast AV conduction made possible by sympathetic drive of exercise On arrival, we obtained another 12-lead: Unremarkable Further history: One month history of shortness of breath on exertion, denies palpitations, chest pain, orthopnea, leg swelling.
Antiarrhythmic Drugs WHAT THEY DO : Antiarrhythmic drugs are used to help prevent or treat abnormal heartrhythms, such as atrialfibrillation and ventricular tachycardia. The most common antiarrhythmic drugs for children with congenital heart disease (CHD) include beta-blockers (see above) and sodium channel blockers.
Atrialfibrillation is the most common heartrhythm disorder in adults, affecting more than 5 million people in the U.S., according to the American Heart Association. The most frequent cardiac arrhythmia, atrialfibrillation, is known to independently increase the risk of dementia, said Massimo Barbagallo, M.D.,
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content